- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07938788
Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism
This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Anja Bosy-Westphal, Prof. Dr. Dr.
- Numero di telefono: +49 431 880 5674
- Email: abosyw@nutrition.uni-kiel.de
Luoghi di studio
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Germania, 24105
- Institute of Human Nutrition and Food Science , Department Human Nutrition
-
Contatto:
- Anja Bosy-Westphal
- Numero di telefono: +49 431 880 5674
- Email: abosyw@nutrition.uni-kiel.de
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Healthy adults with overweight.
- Age 18-60 years.
- Body mass index (BMI) >=25 and <30 kg/m2.
- Men and women; the study plans an equal distribution of biological sex.
- No regular sports participation; regular sporting activity >=2 h/week is excluded.
- German-speaking, because the study questionnaires are in German and not validated in other languages.
- No anemia or iron deficiency based on screening hemoglobin and ferritin.
- Women of childbearing potential must use hormonal contraception (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- - Individuals unable to provide informed written consent.
- Vegetarian or vegan diet.
- Habitual consumption of more than 5 caffeinated beverages per day.
- Chronic diseases.
- Regular medication use, except oral contraceptives.
- Antibiotic use within 6 weeks before study start.
- Anemia and/or iron deficiency.
- Pregnancy or breastfeeding.
- Cigarette and/or cannabis use, including vaping.
- Food allergies and/or food intolerances.
- Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
- Regular sporting activity >=2 h/week.
- Claustrophobia/fear of confined spaces because of EchoMRI assessment.
- Active participation in another study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Control Diet -> Diverse Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
|
Sperimentale: Diverse Diet -> Control Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Postprandial Insulin
Lasso di tempo: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Postprandial Glucose
Lasso di tempo: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
C-Peptide
Lasso di tempo: 24 hours
|
Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter. |
24 hours
|
|
Non-esterified fatty acids
Lasso di tempo: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Triglycerides
Lasso di tempo: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Appetite-relatied hormones (GLP-1, PYY, Ghrelin)
Lasso di tempo: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Subjective Appetite
Lasso di tempo: 0-300 minutes
|
measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side. |
0-300 minutes
|
|
Energy Expenditure and macronutrient oxidation
Lasso di tempo: 24 hours
|
measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
24 hours
|
|
Gut microbiome composition and Microbiome diversity
Lasso di tempo: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
taxonomy and function via shotgun metagenome sequencing |
Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ABW-2026-GRK
- 54453043/GRK3128 (Altro numero di sovvenzione/finanziamento: DFG)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .